These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21813777)

  • 1. Physiologic control of IDO competence in splenic dendritic cells.
    Baban B; Chandler PR; Johnson BA; Huang L; Li M; Sharpe ML; Francisco LM; Sharpe AH; Blazar BR; Munn DH; Mellor AL
    J Immunol; 2011 Sep; 187(5):2329-35. PubMed ID: 21813777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
    Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
    J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase.
    Johnson BA; Kahler DJ; Baban B; Chandler PR; Kang B; Shimoda M; Koni PA; Pihkala J; Vilagos B; Busslinger M; Munn DH; Mellor AL
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10644-8. PubMed ID: 20498068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.
    Baban B; Chandler PR; Sharma MD; Pihkala J; Koni PA; Munn DH; Mellor AL
    J Immunol; 2009 Aug; 183(4):2475-83. PubMed ID: 19635913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
    Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
    Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.
    Park MJ; Park KS; Park HS; Cho ML; Hwang SY; Min SY; Park MK; Park SH; Kim HY
    Cell Immunol; 2012; 278(1-2):45-54. PubMed ID: 23121975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
    Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR
    J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
    Mellor AL; Baban B; Chandler PR; Manlapat A; Kahler DJ; Munn DH
    J Immunol; 2005 Nov; 175(9):5601-5. PubMed ID: 16237046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
    Munn DH; Sharma MD; Mellor AL
    J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.
    Yan Y; Zhang GX; Gran B; Fallarino F; Yu S; Li H; Cullimore ML; Rostami A; Xu H
    J Immunol; 2010 Nov; 185(10):5953-61. PubMed ID: 20944000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
    Kahler DJ; Mellor AL
    Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
    Chung DJ; Rossi M; Romano E; Ghith J; Yuan J; Munn DH; Young JW
    Blood; 2009 Jul; 114(3):555-63. PubMed ID: 19465693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.
    Wingender G; Garbi N; Schumak B; Jüngerkes F; Endl E; von Bubnoff D; Steitz J; Striegler J; Moldenhauer G; Tüting T; Heit A; Huster KM; Takikawa O; Akira S; Busch DH; Wagner H; Hämmerling GJ; Knolle PA; Limmer A
    Eur J Immunol; 2006 Jan; 36(1):12-20. PubMed ID: 16323249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
    Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
    Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
    Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
    Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.
    Jürgens B; Hainz U; Fuchs D; Felzmann T; Heitger A
    Blood; 2009 Oct; 114(15):3235-43. PubMed ID: 19625705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.
    Paveglio SA; Allard J; Foster Hodgkins SR; Ather JL; Bevelander M; Campbell JM; Whittaker LeClair LA; McCarthy SM; van der Vliet A; Suratt BT; Boyson JE; Uematsu S; Akira S; Poynter ME
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):11-23. PubMed ID: 20118221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.
    Huang L; Lemos HP; Li L; Li M; Chandler PR; Baban B; McGaha TL; Ravishankar B; Lee JR; Munn DH; Mellor AL
    J Immunol; 2012 May; 188(10):4913-20. PubMed ID: 22516958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.